Takeda, Astellas Found New JV To Support Japanese Bioventures
Collab With SMBC
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
